Clinical Trial Update: Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial in glioblastoma multiforme evaluating radiation therapy and temozolomide followed by temozolomide plus sorafenib. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Nexavar (Sorafenib)
• Temodar (Temozolomide)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2012-12-13